Pharmaceuticals

Candin Market 2026 evolving with immunotherapy advancements

March 25, 2026March 25, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Increase Is Anticipated For The Candin Market Over The 2026–2030 Period?

Historical growth stemmed from several factors, including the imperative for evaluating immune system capability, the widespread adoption of DTH testing methods, the expansion of diagnostic services within hospitals, the increasing application of immunosuppressive treatments, and the overall development of clinical immunology.

Anticipated growth during the forecast period is propelled by factors such as an increase in immunodeficiency prevalence, broader implementation of immune monitoring protocols, a rise in diagnostic testing volumes, enhanced clinical awareness, and ongoing development of healthcare infrastructure.

Significant trends for the forecast period involve the expanding utilization of immune function diagnostic tests, a broader scope for cell-mediated immunity assessment, an increasing demand for diagnostic skin testing, a heightened focus on detecting immunosuppressive disorders, and the reinforcement of hospital-based diagnostic services.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20011&type=smp

Which Major Factors Are Driving The Expansion Of The Candin Market?

The growing occurrence of tuberculosis is projected to boost the expansion of the candin market. Tuberculosis (TB), an infectious illness caused by Mycobacterium tuberculosis, primarily impacts the lungs but can affect other body parts, spreading via airborne droplets from infected individuals. The increase in TB cases stems from factors including higher transmission from unaddressed or undiagnosed infections, the emergence of drug-resistant strains, deficits in healthcare accessibility, population migration, and the effects of co-infections such as HIV, which compromise immune systems. Candin supports tuberculosis diagnosis by functioning as a control in skin tests to assess cell-mediated immunity, differentiating immune reactions from Mycobacterium tuberculosis from nonspecific anergic responses in patients suspected of having tuberculosis or those with weakened immune systems. For example, the Centers for Disease Control and Prevention, a US-based national public health organization, reported in November 2024 that the United States experienced 9,633 tuberculosis cases in 2023, indicating a 15.6% increase from the 8,332 cases documented in 2022. Consequently, the rising prevalence of tuberculosis is stimulating the growth of the candin market.

How Is The Candin Market Segmented Across Key Categories?

The candin market covered in this report is segmented –

1) By Indication: Candidiasis, Thrush

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By End Use: Hospitals, Clinics, Ambulatory Care, Home Care

Which Upcoming Trends Are Expected To Influence The Candin Market?

A key development in the candin market involves focusing on establishing strategic collaborations to deliver non-invasive, economical, and effective treatment options. Strategic partnerships signify cooperative arrangements between two or more entities aimed at leveraging each other’s advantages, resources, or expertise to fulfill shared objectives, frequently incorporating mutual risks, rewards, and obligations in areas such as product innovation, market expansion, or technological advancement. For example, in May 2023, Nielsen BioSciences Inc., a US-based pharmaceutical company, revealed that it had finalized a licensing agreement with Maruho Co. Ltd., a Japan-based pharmaceutical company, for the sale of candin in Japan as a remedy for verruca vulgaris. Consequent to this partnership, Maruho is set to provide a significant upfront payment to Nielsen and will cover all expenditures associated with the subsequent development and regulatory procedures for Candin, a diagnostic skin test designed to address verruca vulgaris (common warts).

Who Are The Dominant Players Shaping The Candin Market Landscape?

Major companies operating in the candin market are Nielsen BioSciences Inc.

Read the full candin market report here:

https://www.thebusinessresearchcompany.com/report/candin-global-market-report

Which Region Currently Holds The Largest Share Of The Candin Market?

North America was the largest region in the candin market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the candin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Candin Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20011&type=smp

Browse Through More Reports Similar to the Global Candin Market 2026, By The Business Research Company

Candidiasis Therapeutics Market Report 2026

https://www.thebusinessresearchcompany.com/report/candidiasis-therapeutics-global-market-report

Systemic Aspergillosis And Systemic Candidiasis Market Report 2026

https://www.thebusinessresearchcompany.com/report/systemic-aspergillosis-and-systemic-candidiasis-global-market-report

Specialty Yeast Market Report 2026

https://www.thebusinessresearchcompany.com/report/specialty-yeast-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795